openPR Logo
Press release

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share, Size & Growth Forecast by 2033

01-29-2025 04:53 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market

The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market size is projected to grow from USD 6.04 billion in 2023 to USD 9.08 billion by 2030, exhibiting a CAGR of 6% during the forecast period.

The Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report offers information on the most recent market trends and advancements. This report highlights the market's main growth prospects and offers suggestions for how market players can take advantage of them. All things considered, the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market report is a vital tool for market players seeking to comprehend the market thoroughly and spot expansion prospects. The report offers details on the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market's evolving investment structure, growth drivers, technologies, and market trends and development.

๐“๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ข๐ฌ ๐š๐ฅ๐ฌ๐จ ๐š๐ฏ๐š๐ข๐ฅ๐š๐›๐ฅ๐ž ๐ข๐ง ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ฅ๐š๐ง๐ ๐ฎ๐š๐ ๐ž๐ฌ: Japanese (ๅŒ–ๅญฆ็™‚ๆณ•่ช˜็™บๆ€งๅใๆฐ—ใŠใ‚ˆใณๅ˜”ๅ๏ผˆCINV๏ผ‰่–ฌๅธ‚ๅ ด), Korea (ํ™”ํ•™ ์š”๋ฒ•์œผ๋กœ ์ธํ•œ ๋ฉ”์Šค๊บผ์›€ ๋ฐ ๊ตฌํ†  (CINV) ์•ฝ๋ฌผ ์‹œ์žฅ), china (ๅŒ–็–—ๅผ•่ตท็š„ๆถๅฟƒๅ’Œๅ‘•ๅ (CINV) ่ฏ็‰ฉๅธ‚ๅœบ), French (Marchรฉ des mรฉdicaments contre les nausรฉes et vomissements induits par la chimiothรฉrapie (CINV)), German (Markt fรผr Medikamente gegen durch Chemotherapie verursachte รœbelkeit und Erbrechen (CINV).), and Italy (Mercato dei farmaci per nausea e vomito indotti da chemioterapia (CINV).), etc.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐€ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ.

https://exactitudeconsultancy.com/reports/35075/chemotherapy-induced-nausea-and-vomiting-cinv-drugs-market/#request-a-sample

๐Š๐ž๐ฒ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐๐ซ๐จ๐Ÿ๐ข๐ฅ๐ž๐

Amneal Pharmaceuticals, Kyowa Kirin, Tesaro, Acacia Pharma, Heron Therapeutics, Cadila Pharmaceuticals Limited, Helsinn Holding S.A., Insys Therapeutics, GlaxoSmithKline plc, Merck & Co., Eisai Co., Ltd, Hoffmann-La Roche Ltd., Sandoz, Cipla Ltd, Orchid Pharma Ltd, AdvaCare Pharma, Mundipharma, Cinfa Biotech, Oncobiologics, Mylan N.V.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by Form

Injectable

Oral

Transdermal Patches

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by Drug Class

5-HT3 Receptor Antagonists

Neurokinin-1 Receptor Antagonists

Corticosteroids

Cannabinoids

Others

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by Emetogenik Risk

Highly Emetogenic Chemotherapy (HEC)

Moderately Emetogenic Chemotherapy (MEC)

Low Emetogenic Chemotherapy (LEC)

Exploring Key Geographies in Market Growth

North America (U.S., Canada, and others)

Europe (U.K., France, Germany, Russia, and others)

Asia-Pacific (China, Japan, India, Australia, and others)

Middle East & Africa (South Africa, Saudi Arabia, and others)

South America (Brazil, Argentina, and others)

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ก๐ž๐ซ๐ž:

https://exactitudeconsultancy.com/reports/35075/chemotherapy-induced-nausea-and-vomiting-cinv-drugs-market/

๐“๐š๐›๐ฅ๐ž ๐จ๐Ÿ ๐‚๐จ๐ง๐ญ๐ž๐ง๐ญ๐ฌ:

- Market Summary

- Economic Impact Competition Analysis by Players

- Production, Revenue (Value) by geographical segmentation

- Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type and Application

- Regional Market Status and outlook

- Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and outlook

- Market Forecast by Region, Type, and Application

- Cost Investigation, Market Dynamics

- Marketing Strategy comprehension, Distributors and Traders

- Market Effect Factor Analysis

- Research Finding/ Conclusion

- Appendix

๐๐ฎ๐ฒ ๐๐จ๐ฐ:

https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=35075

๐–๐ก๐š๐ญ ๐ˆ๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ž๐ ๐ˆ๐ง ๐“๐ก๐ž ๐†๐ฅ๐จ๐›๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ?

- Market Size Analysis: Analyze the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market size by key regions, countries, product types, and applications.

- Market Segmentation Analysis: Identify various subsegments within the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market for effective categorization.

- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.

- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

- Market Contribution: Evaluate contributions of different segments to the overall Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market growth.

- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

- Industry Challenges: Analyze challenges and risks affecting the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market.

- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง

-20% free customization.

-Five Countries can be added as per your choice.

-Five Companies can added as per your choice.

-Free customization up to 40 hours.

-Post-sales support for 1 year from the date of delivery.

๐Ž๐ญ๐ก๐ž๐ซ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

https://smb.magnoliastatelive.com/article/Dairy-Processing-Equipment-Market-Growth-Industry-Analysis-and-Statistics-2024-2030-Exactitude-Consultancy?storyId=668284d5137b83ff8fb7b003

https://smb.greenvilleadvocate.com/article/Passenger-Vehicle-Supercharger-Market-is-expected-to-grow-at-527percent-CAGR-from-2024-to-2030-Exclusive-Report-by-Exactitude-Consultancy?storyId=668a44d1137b83ff8f99318c

https://pr.chillicothevoice.com/article/Contact-Adhesive-Market-is-expected-to-reach-above-USD-720-Billion-by-2029-Exactitude-Consultancy?storyId=668e9136cccb8328db6f90e7

https://www.micronesiabusinessdaily.com/article/728621293-3d-semiconductor-packaging-market-outlook-report-2024-report-which-provides-an-in-depth-analysis-based-on-regions-applications-exactitude

https://www.bahamasbusinesstimes.com/article/723357149-bicycle-maket-size-status-and-industry-trends-outlook-report-2024-2030-exactitude-consultancy

https://smb.cordeledispatch.com/article/Multirotor-Drones-Market-is-expected-to-be-valued-at-USD-1015-billion-by-2029-or-Exactitude-Consultancy?storyId=66a8ef37709b0518e4dbe826

https://www.moneybankingandme.com/article/733380032-toluene-market-is-expected-to-be-valued-at-usd-66-27-billion-by-2033-exactitude-consultancy

https://www.asiapacificherald.com/article/736765690-engineering-plastics-market-is-expected-to-be-valued-at-usd-200-16-billion-by-2033-exactitude-consultancy

https://www.trinidadtobagobusinessnews.com/article/738585078-global-3d-printing-glasses-market-projected-to-reach-usd-1-450-33-million-by-2033-growing-at-a-cagr-of-8-1

http://www.financeindustrytoday.com/article/745283658-wireless-gas-detection-market-is-projected-to-grow-at-a-cagr-of-7-2-from-2024-to-2031-exactitude-consultancy

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐š๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐ฌ๐ข๐ญ๐ž๐ฌ:

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ฎ๐ฌ:

Exactitude Consultancy

PHONE NUMBER +1 (704) 266-3234

EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share, Size & Growth Forecast by 2033 here

News-ID: 3838065 • Views: โ€ฆ

More Releases from Exactitude Consultancy

Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epilepsy Prevalence & Breakthrough Anti-Seizure Therapies
Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epile โ€ฆ
Pune, India - December 2025 - The global Partial Seizure Market, valued at USD 6.82 billion in 2024, is projected to reach USD 11.24 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing global epilepsy burden, development of new anti-seizure medications (ASMs), and expanded access to neurological diagnostics are fueling strong market growth. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/72069 Market Summary The Partial Seizure Marketโ€ฆ
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion by 2034, growing at a 4.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of focal (partial) seizures, development of improved anti-epileptic drugs (AEDs), and advancements in neuroimaging and neuromodulation therapies are key growth drivers. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/72067 Market Summary The Partialโ€ฆ
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 19.42 Billion by 2034
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 โ€ฆ
Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is projected to reach USD 19.42 billion by 2034, growing at a robust 11.0% CAGR (2025-2034), according to Exactitude Consultancy. Rapid advancements in AAV-based gene therapies, antisense oligonucleotides (ASOs), RNA-targeting technologies, and improved diagnostic pathways are driving strong market momentum. Download Full PDF Sample Copy of Marketโ€ฆ
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Diabetes Risk & Digital Health Programs
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Di โ€ฆ
Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by 2034, growing at a 7.2% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of insulin resistance, sedentary lifestyles, obesity, and increased screening initiatives are fueling substantial market growth. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/72063 Market Summary The Prediabetes Market is expanding rapidly as healthcareโ€ฆ

All 5 Releases


More Releases for CINV

Rising Cancer Prevalence Spurs Growth In The Chemotherapy-Induced Nausea And Vom โ€ฆ
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Forecast: What to Expect by 2025? In recent times, the market encompassing chemotherapy-induced nausea and vomiting treatments has witnessed substantial expansion, projected to increase its valuation from $2.92 billion in 2024 to $3.13 billion in 2025, reflecting a compound annual growthโ€ฆ
CINV Treatment Market to Reach USD 3.9 Billion by 2034
Pune, India, November 11, 2025 - The global Chemotherapy-Induced Nausea and Vomiting (CINV) Treatment Market is projected to grow from USD 2.6 billion in 2024 to USD 3.9 billion by 2034, registering a CAGR of 4.1 %, according to Exactitude Consultancy. Rising cancer incidence, increasing chemotherapy adoption, and development of next-generation serotonin (5-HT3) and neurokinin-1 (NK1) receptor antagonists are driving global market expansion. Download Full PDF Sample Copy of Market Reportโ€ฆ
Emerging Trends Influencing The Growth Of The Chemotherapy-Induced Nausea and Vo โ€ฆ
The Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Expected to Be by 2034? There has been a notable growth in the market size of chemotherapy-induced nausea and vomiting (CINV)โ€ฆ
Key Influencer in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market 202 โ€ฆ
How Are the key drivers contributing to the expansion of the chemotherapy-induced nausea and vomiting (cinv) market? The escalating cases of cancer are expected to foster the expansion of the market for chemotherapy-induced nausea and vomiting (CINV). This rise is due to the uncontrolled development and spread of cancer cells in the body. As cancer prevalence increases, there's an increased drive to produce highly effective and specific anti-emetic treatments, which wouldโ€ฆ
CINV Existing and Pipeline Drugs Market: Rising Demand for CINV Drugs Owing to I โ€ฆ
CINV drugs are administered to patients suffering from vomiting and nausea that occurs as a side effect of chemotherapy. CINV can hinder the progress of patients undergoing chemotherapy, making it very crucial for oncologists to prescribe the right kind of CINV drugs to alleviate the discomfort. Delayed CINV and acute CINV are the two major subtypes of this condition. While the former occurs up to five days after treatment, theโ€ฆ
CINV Existing and Pipeline Drugs Market : Growing number of patients undergoing โ€ฆ
The growth of the global chemotherapy induced nausea and vomiting (CINV) market will be steered by the growing number of patients undergoing chemotherapy and a number of new drugs expected to be approved in the near future, says Transparency Market Research. In its report, titled โ€œCINV Existing and Pipeline Drugs Market โ€“ Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 โ€“ 2020,โ€ the business intelligence firm says thatโ€ฆ